ArticleFrontiers in immunology2025

Safety profile of complement C5 inhibitors and FcRn inhibitors in the treatment of myasthenia gravis: analysis of the FAERS database and disease-gene interaction network.

Luqiong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.